series-c-plus
Stage
2
Investors
About
BenevolentAI develops an AI-driven platform that uses machine learning and proprietary knowledge graphs to enhance and accelerate drug discovery and life science research.
Explore BenevolentAI's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.